Come stop by to see CPP as we will be exhibiting at the AAP National Conference & Exhibition, alongside Nationwide Children’s Hospital (booth # 2217) in the exhibit hall during the conference!
Related Posts
This month, CPP members participating in either Sanofi or Pfizer programs can take advantage of additional vaccine savings opportunities. Sanofi…
The United States is witnessing a troubling rise in measles cases, with a significant outbreak in Texas reaching 90 confirmed…
Come visit the CPP exhibit table at the Ohio AAP Annual Meeting on Friday, October 18th at Hilton Polaris in…
Attending the 2024 AAFP’s Family Medicine Experience (FMX) conference in Phoenix? As an exhibitor, CPP Buying Group is excited to…
Friday, March 31, 2023, is the last day to prebook Fluzone®, High-Dose Fluzone and Flublok® vaccines for the 2023-2024 flu…
CPP will be attending and exhibiting at the 2025 American Medical Group Association (AMGA) Annual Conference in Grapevine, TX March…
Stop by to see CPP as we will be exhibiting at the AAP National Conference & Exhibition September 27th-October 1st,…
It’s time for your annual vaccine management check-up! This tool is designed to help you check up on the financial…
Vaccine Updates – Pfizer Recently, Pfizer communicated some changes to their vaccine portfolio. The addition of Pfizer’s Penbraya™, a new pentavalent…
The first of the year is usually when vaccine manufacturers increase their prices therefore, it is important that practices evaluate…
CPP members don’t forget that Friday, April,19th, is the last day to pre-book Fluzone®, High-Dose Fluzone and Flublok® vaccines for…
CPP will be attending and exhibiting at the 2024 AMGA Annual Conference in sunny Orlando, FL April 9-12. Stop by…
RSV is a significant concern for infants and young children, often leading to hospitalizations. Surveys by the AAP show that…
Protecting patients against vaccine-preventable diseases is a critical part of keeping patients healthy. Physician buying groups enable practices to optimize…
RSV MONOCLONAL ANTIBODY (INFANTS) On August 3rd, the ACIP voted unanimously and recommended the use of Sanofi and AstraZeneca’s Beyfortus™,…